Global Bio-protein Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bio-protein Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bio-protein Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bio-protein Drug by Country/Region, 2017, 2022 & 2028

2.2 Bio-protein Drug Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Therapeutic Proteins

2.2.3 Vaccines

2.3 Bio-protein Drug Sales by Type

2.3.1 Global Bio-protein Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Bio-protein Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bio-protein Drug Sale Price by Type (2017-2022)

2.4 Bio-protein Drug Segment by Application

2.4.1 Pharma and Biotech Companies

2.4.2 CROs

2.4.3 Academics

2.5 Bio-protein Drug Sales by Application

2.5.1 Global Bio-protein Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Bio-protein Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bio-protein Drug Sale Price by Application (2017-2022)

3 Global Bio-protein Drug by Company

3.1 Global Bio-protein Drug Breakdown Data by Company

3.1.1 Global Bio-protein Drug Annual Sales by Company (2020-2022)

3.1.2 Global Bio-protein Drug Sales Market Share by Company (2020-2022)

3.2 Global Bio-protein Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Bio-protein Drug Revenue by Company (2020-2022)

3.2.2 Global Bio-protein Drug Revenue Market Share by Company (2020-2022)

3.3 Global Bio-protein Drug Sale Price by Company

3.4 Key Manufacturers Bio-protein Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bio-protein Drug Product Location Distribution

3.4.2 Players Bio-protein Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bio-protein Drug by Geographic Region

4.1 World Historic Bio-protein Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Bio-protein Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bio-protein Drug Annual Revenue by Geographic Region

4.2 World Historic Bio-protein Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Bio-protein Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bio-protein Drug Annual Revenue by Country/Region

4.3 Americas Bio-protein Drug Sales Growth

4.4 APAC Bio-protein Drug Sales Growth

4.5 Europe Bio-protein Drug Sales Growth

4.6 Middle East & Africa Bio-protein Drug Sales Growth

5 Americas

5.1 Americas Bio-protein Drug Sales by Country

5.1.1 Americas Bio-protein Drug Sales by Country (2017-2022)

5.1.2 Americas Bio-protein Drug Revenue by Country (2017-2022)

5.2 Americas Bio-protein Drug Sales by Type

5.3 Americas Bio-protein Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bio-protein Drug Sales by Region

6.1.1 APAC Bio-protein Drug Sales by Region (2017-2022)

6.1.2 APAC Bio-protein Drug Revenue by Region (2017-2022)

6.2 APAC Bio-protein Drug Sales by Type

6.3 APAC Bio-protein Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bio-protein Drug by Country

7.1.1 Europe Bio-protein Drug Sales by Country (2017-2022)

7.1.2 Europe Bio-protein Drug Revenue by Country (2017-2022)

7.2 Europe Bio-protein Drug Sales by Type

7.3 Europe Bio-protein Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bio-protein Drug by Country

8.1.1 Middle East & Africa Bio-protein Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bio-protein Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Bio-protein Drug Sales by Type

8.3 Middle East & Africa Bio-protein Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bio-protein Drug

10.3 Manufacturing Process Analysis of Bio-protein Drug

10.4 Industry Chain Structure of Bio-protein Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bio-protein Drug Distributors

11.3 Bio-protein Drug Customer

12 World Forecast Review for Bio-protein Drug by Geographic Region

12.1 Global Bio-protein Drug Market Size Forecast by Region

12.1.1 Global Bio-protein Drug Forecast by Region (2023-2028)

12.1.2 Global Bio-protein Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bio-protein Drug Forecast by Type

12.7 Global Bio-protein Drug Forecast by Application

13 Key Players Analysis

13.1 Abbott Laboratories

13.1.1 Abbott Laboratories Company Information

13.1.2 Abbott Laboratories Bio-protein Drug Product Offered

13.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Laboratories Main Business Overview

13.1.5 Abbott Laboratories Latest Developments

13.2 Bayer AG

13.2.1 Bayer AG Company Information

13.2.2 Bayer AG Bio-protein Drug Product Offered

13.2.3 Bayer AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer AG Main Business Overview

13.2.5 Bayer AG Latest Developments

13.3 Eli Lilly and Company

13.3.1 Eli Lilly and Company Company Information

13.3.2 Eli Lilly and Company Bio-protein Drug Product Offered

13.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Eli Lilly and Company Main Business Overview

13.3.5 Eli Lilly and Company Latest Developments

13.4 Amgen Inc.

13.4.1 Amgen Inc. Company Information

13.4.2 Amgen Inc. Bio-protein Drug Product Offered

13.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amgen Inc. Main Business Overview

13.4.5 Amgen Inc. Latest Developments

13.5 Biocon Ltd.

13.5.1 Biocon Ltd. Company Information

13.5.2 Biocon Ltd. Bio-protein Drug Product Offered

13.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biocon Ltd. Main Business Overview

13.5.5 Biocon Ltd. Latest Developments

13.6 Dr. Reddy’s Laboratories

13.6.1 Dr. Reddy’s Laboratories Company Information

13.6.2 Dr. Reddy’s Laboratories Bio-protein Drug Product Offered

13.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr. Reddy’s Laboratories Main Business Overview

13.6.5 Dr. Reddy’s Laboratories Latest Developments

13.7 Roche

13.7.1 Roche Company Information

13.7.2 Roche Bio-protein Drug Product Offered

13.7.3 Roche Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Roche Main Business Overview

13.7.5 Roche Latest Developments

13.8 Fresenius kabi

13.8.1 Fresenius kabi Company Information

13.8.2 Fresenius kabi Bio-protein Drug Product Offered

13.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Fresenius kabi Main Business Overview

13.8.5 Fresenius kabi Latest Developments

13.9 GlaxoSmithKline

13.9.1 GlaxoSmithKline Company Information

13.9.2 GlaxoSmithKline Bio-protein Drug Product Offered

13.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 GlaxoSmithKline Main Business Overview

13.9.5 GlaxoSmithKline Latest Developments

13.10 Johnson & Johnson

13.10.1 Johnson & Johnson Company Information

13.10.2 Johnson & Johnson Bio-protein Drug Product Offered

13.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Johnson & Johnson Main Business Overview

13.10.5 Johnson & Johnson Latest Developments

13.11 Merck

13.11.1 Merck Company Information

13.11.2 Merck Bio-protein Drug Product Offered

13.11.3 Merck Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Merck Main Business Overview

13.11.5 Merck Latest Developments

13.12 Novartis AG

13.12.1 Novartis AG Company Information

13.12.2 Novartis AG Bio-protein Drug Product Offered

13.12.3 Novartis AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Novartis AG Main Business Overview

13.12.5 Novartis AG Latest Developments

13.13 Panacea Biotec

13.13.1 Panacea Biotec Company Information

13.13.2 Panacea Biotec Bio-protein Drug Product Offered

13.13.3 Panacea Biotec Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Panacea Biotec Main Business Overview

13.13.5 Panacea Biotec Latest Developments

13.14 ProBioGen AG

13.14.1 ProBioGen AG Company Information

13.14.2 ProBioGen AG Bio-protein Drug Product Offered

13.14.3 ProBioGen AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 ProBioGen AG Main Business Overview

13.14.5 ProBioGen AG Latest Developments

13.15 Sanofi

13.15.1 Sanofi Company Information

13.15.2 Sanofi Bio-protein Drug Product Offered

13.15.3 Sanofi Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Sanofi Main Business Overview

13.15.5 Sanofi Latest Developments

13.16 Reliance Life Science Pvt. Ltd.

13.16.1 Reliance Life Science Pvt. Ltd. Company Information

13.16.2 Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Offered

13.16.3 Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Reliance Life Science Pvt. Ltd. Main Business Overview

13.16.5 Reliance Life Science Pvt. Ltd. Latest Developments

14 Research Findings and Conclusion

Table 1. Bio-protein Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bio-protein Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal Antibodies

Table 4. Major Players of Therapeutic Proteins

Table 5. Major Players of Vaccines

Table 6. Global Bio-protein Drug Sales by Type (2017-2022) & (K Units)

Table 7. Global Bio-protein Drug Sales Market Share by Type (2017-2022)

Table 8. Global Bio-protein Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Bio-protein Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Bio-protein Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Bio-protein Drug Sales by Application (2017-2022) & (K Units)

Table 12. Global Bio-protein Drug Sales Market Share by Application (2017-2022)

Table 13. Global Bio-protein Drug Revenue by Application (2017-2022)

Table 14. Global Bio-protein Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Bio-protein Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Bio-protein Drug Sales by Company (2020-2022) & (K Units)

Table 17. Global Bio-protein Drug Sales Market Share by Company (2020-2022)

Table 18. Global Bio-protein Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Bio-protein Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Bio-protein Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Bio-protein Drug Producing Area Distribution and Sales Area

Table 22. Players Bio-protein Drug Products Offered

Table 23. Bio-protein Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Bio-protein Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Bio-protein Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Bio-protein Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Bio-protein Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Bio-protein Drug Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Bio-protein Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Bio-protein Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Bio-protein Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Bio-protein Drug Sales by Country (2017-2022) & (K Units)

Table 35. Americas Bio-protein Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Bio-protein Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Bio-protein Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Bio-protein Drug Sales by Type (2017-2022) & (K Units)

Table 39. Americas Bio-protein Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Bio-protein Drug Sales by Application (2017-2022) & (K Units)

Table 41. Americas Bio-protein Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Bio-protein Drug Sales by Region (2017-2022) & (K Units)

Table 43. APAC Bio-protein Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Bio-protein Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Bio-protein Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Bio-protein Drug Sales by Type (2017-2022) & (K Units)

Table 47. APAC Bio-protein Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Bio-protein Drug Sales by Application (2017-2022) & (K Units)

Table 49. APAC Bio-protein Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Bio-protein Drug Sales by Country (2017-2022) & (K Units)

Table 51. Europe Bio-protein Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Bio-protein Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Bio-protein Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Bio-protein Drug Sales by Type (2017-2022) & (K Units)

Table 55. Europe Bio-protein Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Bio-protein Drug Sales by Application (2017-2022) & (K Units)

Table 57. Europe Bio-protein Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Bio-protein Drug Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Bio-protein Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Bio-protein Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Bio-protein Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Bio-protein Drug Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Bio-protein Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Bio-protein Drug Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Bio-protein Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Bio-protein Drug

Table 67. Key Market Challenges & Risks of Bio-protein Drug

Table 68. Key Industry Trends of Bio-protein Drug

Table 69. Bio-protein Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Bio-protein Drug Distributors List

Table 72. Bio-protein Drug Customer List

Table 73. Global Bio-protein Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Bio-protein Drug Sales Market Forecast by Region

Table 75. Global Bio-protein Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Bio-protein Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Bio-protein Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Bio-protein Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Bio-protein Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Bio-protein Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Bio-protein Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Bio-protein Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Bio-protein Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Bio-protein Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Bio-protein Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Bio-protein Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Bio-protein Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Bio-protein Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Bio-protein Drug Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Bio-protein Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Bio-protein Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Bio-protein Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Abbott Laboratories Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Abbott Laboratories Bio-protein Drug Product Offered

Table 95. Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Abbott Laboratories Main Business

Table 97. Abbott Laboratories Latest Developments

Table 98. Bayer AG Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Bayer AG Bio-protein Drug Product Offered

Table 100. Bayer AG Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Bayer AG Main Business

Table 102. Bayer AG Latest Developments

Table 103. Eli Lilly and Company Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Eli Lilly and Company Bio-protein Drug Product Offered

Table 105. Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Eli Lilly and Company Main Business

Table 107. Eli Lilly and Company Latest Developments

Table 108. Amgen Inc. Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. Amgen Inc. Bio-protein Drug Product Offered

Table 110. Amgen Inc. Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Amgen Inc. Main Business

Table 112. Amgen Inc. Latest Developments

Table 113. Biocon Ltd. Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Biocon Ltd. Bio-protein Drug Product Offered

Table 115. Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Biocon Ltd. Main Business

Table 117. Biocon Ltd. Latest Developments

Table 118. Dr. Reddy’s Laboratories Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Dr. Reddy’s Laboratories Bio-protein Drug Product Offered

Table 120. Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Dr. Reddy’s Laboratories Main Business

Table 122. Dr. Reddy’s Laboratories Latest Developments

Table 123. Roche Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Roche Bio-protein Drug Product Offered

Table 125. Roche Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Roche Main Business

Table 127. Roche Latest Developments

Table 128. Fresenius kabi Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Fresenius kabi Bio-protein Drug Product Offered

Table 130. Fresenius kabi Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Fresenius kabi Main Business

Table 132. Fresenius kabi Latest Developments

Table 133. GlaxoSmithKline Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. GlaxoSmithKline Bio-protein Drug Product Offered

Table 135. GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. GlaxoSmithKline Main Business

Table 137. GlaxoSmithKline Latest Developments

Table 138. Johnson & Johnson Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. Johnson & Johnson Bio-protein Drug Product Offered

Table 140. Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Johnson & Johnson Main Business

Table 142. Johnson & Johnson Latest Developments

Table 143. Merck Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. Merck Bio-protein Drug Product Offered

Table 145. Merck Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Merck Main Business

Table 147. Merck Latest Developments

Table 148. Novartis AG Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. Novartis AG Bio-protein Drug Product Offered

Table 150. Novartis AG Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Novartis AG Main Business

Table 152. Novartis AG Latest Developments

Table 153. Panacea Biotec Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Panacea Biotec Bio-protein Drug Product Offered

Table 155. Panacea Biotec Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Panacea Biotec Main Business

Table 157. Panacea Biotec Latest Developments

Table 158. ProBioGen AG Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. ProBioGen AG Bio-protein Drug Product Offered

Table 160. ProBioGen AG Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. ProBioGen AG Main Business

Table 162. ProBioGen AG Latest Developments

Table 163. Sanofi Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. Sanofi Bio-protein Drug Product Offered

Table 165. Sanofi Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 166. Sanofi Main Business

Table 167. Sanofi Latest Developments

Table 168. Reliance Life Science Pvt. Ltd. Basic Information, Bio-protein Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Reliance Life Science Pvt. Ltd. Bio-protein Drug Product Offered

Table 170. Reliance Life Science Pvt. Ltd. Bio-protein Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 171. Reliance Life Science Pvt. Ltd. Main Business

Table 172. Reliance Life Science Pvt. Ltd. Latest Developments

List of Figures

Figure 1. Picture of Bio-protein Drug

Figure 2. Bio-protein Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bio-protein Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bio-protein Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bio-protein Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal Antibodies

Figure 10. Product Picture of Therapeutic Proteins

Figure 11. Product Picture of Vaccines

Figure 12. Global Bio-protein Drug Sales Market Share by Type in 2021

Figure 13. Global Bio-protein Drug Revenue Market Share by Type (2017-2022)

Figure 14. Bio-protein Drug Consumed in Pharma and Biotech Companies

Figure 15. Global Bio-protein Drug Market: Pharma and Biotech Companies (2017-2022) & (K Units)

Figure 16. Bio-protein Drug Consumed in CROs

Figure 17. Global Bio-protein Drug Market: CROs (2017-2022) & (K Units)

Figure 18. Bio-protein Drug Consumed in Academics

Figure 19. Global Bio-protein Drug Market: Academics (2017-2022) & (K Units)

Figure 20. Global Bio-protein Drug Sales Market Share by Application (2017-2022)

Figure 21. Global Bio-protein Drug Revenue Market Share by Application in 2021

Figure 22. Bio-protein Drug Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Bio-protein Drug Revenue Market Share by Company in 2021

Figure 24. Global Bio-protein Drug Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Bio-protein Drug Revenue Market Share by Geographic Region in 2021

Figure 26. Global Bio-protein Drug Sales Market Share by Region (2017-2022)

Figure 27. Global Bio-protein Drug Revenue Market Share by Country/Region in 2021

Figure 28. Americas Bio-protein Drug Sales 2017-2022 (K Units)

Figure 29. Americas Bio-protein Drug Revenue 2017-2022 ($ Millions)

Figure 30. APAC Bio-protein Drug Sales 2017-2022 (K Units)

Figure 31. APAC Bio-protein Drug Revenue 2017-2022 ($ Millions)

Figure 32. Europe Bio-protein Drug Sales 2017-2022 (K Units)

Figure 33. Europe Bio-protein Drug Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Bio-protein Drug Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Bio-protein Drug Revenue 2017-2022 ($ Millions)

Figure 36. Americas Bio-protein Drug Sales Market Share by Country in 2021

Figure 37. Americas Bio-protein Drug Revenue Market Share by Country in 2021

Figure 38. United States Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Bio-protein Drug Sales Market Share by Region in 2021

Figure 43. APAC Bio-protein Drug Revenue Market Share by Regions in 2021

Figure 44. China Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Bio-protein Drug Sales Market Share by Country in 2021

Figure 51. Europe Bio-protein Drug Revenue Market Share by Country in 2021

Figure 52. Germany Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Bio-protein Drug Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Bio-protein Drug Revenue Market Share by Country in 2021

Figure 59. Egypt Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Bio-protein Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Bio-protein Drug in 2021

Figure 65. Manufacturing Process Analysis of Bio-protein Drug

Figure 66. Industry Chain Structure of Bio-protein Drug

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles